2020

Armeni P, Borsoi L, Fornaro G, Jommi C, Grossi F, Costa F
Cost-effectiveness and Net Monetary Benefit of Durvalumab Consolidation Therapy Versus No Consolidation Therapy After Chemoradiotherapy in Stage III Non-small Cell Lung Cancer in the Italian National Health Service.
Clinical therapeutics,
2020 42(5): 830-847 (link)


Armeni P, Borsoi L, Fornaro G, Jommi C, Colombo N, Costa F
Cost-Effectiveness and Net Monetary Benefit of Olaparib Maintenance Therapy Versus No Maintenance Therapy After First-line Platinum-based Chemotherapy in Newly Diagnosed Advanced BRCA1/2-mutated Ovarian Cancer in the Italian National Health Service.
Clinical therapeutics, 2020 42(7): 1192-1209.e12 (link)


Boscolo PR, Callea G, Ciani O, Tarricone R
Measuring Value in Health Care: A Comparative Analysis of Value-based Frameworks
Clinical therapeutics, 2020 Jan;42(1):34-43 (link)


Ciani O, Federici C
Value Lies in the Eye of Patients:  The Why, What, and How of Patients-Reported Outcomes Measures
Clinical therapeutics, 2020 Jan;42(1):25-33 (link)


Ciani O
Surrogate endpoints and health policy: why validation methods matter
Epidemiologia e Prevenzione, 2020; 44(1): 96-97 (link)


Ciani O, Torbica A, Tarricone R
Core Outcome Set in Surgical Oncology; Why, What and How to measure
in Volume-Outcome Relationship in Oncology Surgery, M. Montorsi (eds) pp.5-13, Springer (link)


Meregaglia M, Whittal A, Nicod E, Drummond M
‘Mapping’ Health State Utility Values from Non-preference-Based Measures: A Systematic Literature Review in Rare Diseases
Pharmacoeconomics, 2020  https://doi.org/10.1007/s40273-020-00897-4 (link)


Meregaglia M, I Croci, C Brusco, LC Herich, D Di Lallo, G Gargano, V Carnielli, J Zeitlin, G Fattore, M Cuttini
Low socio‐economic conditions and prematurity‐related morbidities explain healthcare use and costs for 2‐year‐old very preterm children
Acta Paediatrica, First published: 24 January 2020 (link)


Meregaglia M, Ciani O, Banks H, Salcher-Konrad M, Carney C, Jayawardana S, Williamson P, Fattore G
A scoping review of core outcome sets and their "mapping" onto real-world data using prostate cancer as a case study
BMC Medical research methodology, 20:41 (link)


Rognoni C, Armeni P, Tarricone R
, Donin G
Cost-benefit Analysis in Health Care: The Case of Bariatric Surgery Compared With Diet
Clinical therapeutics
, 2020 Jan;42(1):60-75.e7 (link)


Rognoni C, Tozzi M, Tarricone R
Endovascular versus surgical creation of arteriovenous fistula in hemodialysis patients: Cost-effectiveness and budget impact analyses
The Journal of Vascular Access, 2020, https://doi.org/10.1177/1129729820921021 (link)


Tarricone R, Rognoni C, Arnoldo L, Mazzacane S, Caselli E
A Probiotic-Based Sanitation System for the Reduction of Healthcare Associated Infections and Antimicrobial Resistances: A Budget Impact Analysis
Phatogens, 2020, 9(6): 502 (link)

Tarricone R, Ciani O, Torbica A,  Brouwer w, Chaloutsos G, Drummond MF, Martelli N, Persson U, Leidl L, Levin R, Sampietro-Colom L, Taylor R
Lifecycle evidence requirements for high-risk implantable medical devices: a European perspective
Expert Review of Medical Devices, https://doi.org/10.1080/17434440.2020.1825074 (link)


Torbica A
HTA Around the World: Broadening Our Understanding of Cross-Country Differences.
Value in Health, 2020 Jan;23(1):1-2 (link)


Torbica A, Fornaro G, Tarricone R, Drummond MF
Do Social Values and Institutional Context Shape the Use of Economic Evaluation in Reimbursement Decisions? An Empirical Analysis.
Value in Health, 2020 Jan;23(1):17-24 (link)


Timmis A, Townsend N, Gale CP, Torbica A, Lettino M, Petersen SE, Mossialos EA, Maggioni AP, Kazakiewicz D, May HT, De Smedt D, Flather M, Zuhlke L, Beltrame JF, Huculeci R, Tavazzi L, Hindricks G, Bax J, Casadei B, Achenbach S, Wright L, Vardas P, Vardas P
European Society of Cardiology: Cardiovascular Disease Statistics 2019
European heart journal, 2020 Jan;41(1):12-85 (link)


Wang Y, Fattore G
The impact of great economic crisis on mental health care in Italy
The European Journal of Health Economics, 2020 (link)